Contessi Negrini Nicola, Ricci Claudio, Bongiorni Federica, Trombi Luisa, D'Alessandro Delfo, Danti Serena, Farè Silvia
Department of Chemistry, Materials and Chemical Engineering "G. Natta", Politecnico di Milano, 20131 Milan, Italy.
Department of Civil and Industrial Engineering, University of Pisa, 56122 Pisa, Italy.
Cancers (Basel). 2022 Apr 15;14(8):2003. doi: 10.3390/cancers14082003.
Osteosarcoma is a primary bone tumor characterized by a dismal prognosis, especially in the case of recurrent disease or metastases. Therefore, tools to understand in-depth osteosarcoma progression and ultimately develop new therapeutics are urgently required. 3D in vitro models can provide an optimal option, as they are highly reproducible, yet sufficiently complex, thus reliable alternatives to 2D in vitro and in vivo models. Here, we describe 3D in vitro osteosarcoma models prepared by printing polyurethane (PU) by fused deposition modeling, further enriched with human mesenchymal stromal cell (hMSC)-secreted biomolecules. We printed scaffolds with different morphologies by changing their design (i.e., the distance between printed filaments and printed patterns) to obtain different pore geometry, size, and distribution. The printed PU scaffolds were stable during in vitro cultures, showed adequate porosity (55-67%) and tunable mechanical properties (Young's modulus ranging in 0.5-4.0 MPa), and resulted in cytocompatible. We developed the in vitro model by seeding SAOS-2 cells on the optimal PU scaffold (i.e., 0.7 mm inter-filament distance, 60° pattern), by testing different pre-conditioning factors: none, undifferentiated hMSC-secreted, and osteo-differentiated hMSC-secreted extracellular matrix (ECM), which were obtained by cell lysis before SAOS-2 seeding. Scaffolds pre-cultured with osteo-differentiated hMSCs, subsequently lysed, and seeded with SAOS-2 cells showed optimal colonization, thus disclosing a suitable biomimetic microenvironment for osteosarcoma cells, which can be useful both in tumor biology study and, possibly, treatment.
骨肉瘤是一种原发性骨肿瘤,预后较差,尤其是复发性疾病或发生转移的情况下。因此,迫切需要深入了解骨肉瘤进展并最终开发新疗法的工具。三维体外模型可以提供一个最佳选择,因为它们具有高度可重复性,但又足够复杂,是二维体外模型和体内模型的可靠替代方案。在这里,我们描述了通过熔融沉积建模打印聚氨酯(PU)制备的三维体外骨肉瘤模型,该模型进一步富集了人间充质基质细胞(hMSC)分泌的生物分子。我们通过改变设计(即打印细丝之间的距离和打印图案)来打印具有不同形态的支架,以获得不同的孔隙几何形状、尺寸和分布。打印的PU支架在体外培养过程中稳定,显示出足够的孔隙率(55-67%)和可调的力学性能(杨氏模量在0.5-4.0MPa范围内),并且具有细胞相容性。我们通过将SAOS-2细胞接种在最佳PU支架(即细丝间距0.7mm,图案60°)上,测试不同的预处理因素:无、未分化的hMSC分泌的以及经骨分化的hMSC分泌的细胞外基质(ECM),这些是在SAOS-2接种前通过细胞裂解获得的,从而开发了体外模型。用经骨分化的hMSCs预培养、随后裂解并接种SAOS-2细胞的支架显示出最佳的定植效果,从而揭示了一个适合骨肉瘤细胞的仿生微环境,这在肿瘤生物学研究以及可能的治疗中都可能有用。